Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million

RPRX•2026-08-19

Source note

Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001814238-26-000015), on August 19, 2026, and is solely responsible for the information contained therein.

Insider share sale and gift

Royalty Pharma EVP and Chairman of Partnering Christopher Hite sold 100,000 Class A Ordinary Shares on Aug. 18, 2026.
Sale price: USD 59.97 per share; indirect holding via SCH Investment Partners fell to 370,401 shares.
He also gifted 16,800 Class A Ordinary Shares on Aug. 19, 2026; direct holding fell to 23,200 shares.

Sources

Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million

Sec

Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million

Source note

Insider share sale and gift

Related News

Gerdau backs Gerdau Açominas’ BNDES loan of up to R$ 300 million under Brasil Soberano program

Howard Hughes Holdings announces annual shareholder meeting

NACCO subsidiary Coteau Properties receives MSHA imminent danger order at Freedom Mine

Sources

Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million

TXNM Energy unit PNM sells USD 200 million senior unsecured notes in private placement

Carlyle joins $1 billion investment round in missile startup Castelion